Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PETNET Solutions, a Siemens Healthineers company, is a leading global provider of positron emission tomography (PET) radiopharmaceuticals. The company operates an extensive network of manufacturing facilities equipped with cyclotrons to produce and distribute biomarkers for oncology, neurology, and cardiology. PETNET provides healthcare providers with access to essential tracers such as FDG, as well as specialized proprietary agents for imaging amyloid plaques and prostate-specific membrane antigen. In addition to its own distribution, the company serves as a contract development and manufacturing organization (CDMO) for pharmaceutical partners bringing new PET tracers to market. Their infrastructure supports the entire lifecycle of radiopharmaceuticals from clinical trials to commercial distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PETNET Pharmaceuticals.